Back to Authors

Drummond, Mark W.

A5112197328 | I2800373718

Mayo Clinic

Beatson West of Scotland Cancer Centre

Citations 12

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis

JAMA Oncology | March 8, 2018 | Volume: 4 | Issue: 5 | Pages: 652

10.1001/jamaoncol.2017.5818 | PMID 29522138

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

JAMA Oncology | June 18, 2015 | Volume: 1 | Issue: 5 | Pages: 643

10.1001/jamaoncol.2015.1590 | PMID 26181658